These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9225710)

  • 61. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
    Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
    Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
    King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
    van Laar MW; Volkerts ER; van Willigenburg AP
    J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.
    DeMartinis N; Rynn M; Rickels K; Mandos L
    J Clin Psychiatry; 2000 Feb; 61(2):91-4. PubMed ID: 10732655
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Buspirone for aggression.
    Quiason N; Ward D; Kitchen T
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):1026. PubMed ID: 1757432
    [No Abstract]   [Full Text] [Related]  

  • 67. Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.
    Delle Chiaie R; Pancheri P; Casacchia M; Stratta P; Kotzalidis GD; Zibellini M
    J Clin Psychopharmacol; 1995 Feb; 15(1):12-9. PubMed ID: 7714222
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy.
    Rynn M; García-España F; Greenblatt DJ; Mandos LA; Schweizer E; Rickels K
    J Clin Psychopharmacol; 2003 Oct; 23(5):505-8. PubMed ID: 14520129
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.
    Peoples AR; Bushunow PW; Garland SN; Heckler CE; Roscoe JA; Peppone LL; Dudgeon DJ; Kirshner JJ; Banerjee TK; Hopkins JO; Dakhil SR; Flannery MA; Morrow GR
    Support Care Cancer; 2016 Mar; 24(3):1339-47. PubMed ID: 26329396
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder.
    Childress AC; Spencer T; Lopez F; Gerstner O; Thulasiraman A; Muniz R; Post A
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):351-61. PubMed ID: 19702487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
    Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
    J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictive value of placebo methylphenidate.
    Tirosh E; Elhasid R; Kamah SC; Cohen A
    Pediatr Neurol; 1993; 9(2):131-3. PubMed ID: 8499043
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
    Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
    J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone.
    Fawcett J; Kravitz HM; McGuire M; Easton M; Ross J; Pisani V; Fogg LF; Clark D; Whitney M; Kravitz G; Javaid J; Teas G
    Alcohol Clin Exp Res; 2000 May; 24(5):666-74. PubMed ID: 10832908
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
    Weisler RH; Greenbaum M; Arnold V; Yu M; Yan B; Jaffee M; Robertson B
    CNS Drugs; 2017 Aug; 31(8):685-697. PubMed ID: 28712074
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Teaching children with attention deficit hyperactivity disorder (ADHD) and autistic disorder (AD) how to swallow pills.
    Beck MH; Cataldo M; Slifer KJ; Pulbrook V; Guhman JK
    Clin Pediatr (Phila); 2005; 44(6):515-26. PubMed ID: 16015399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Buspirone in the treatment of alcohol dependence: a placebo-controlled trial.
    Malec E; Malec T; Gagné MA; Dongier M
    Alcohol Clin Exp Res; 1996 Apr; 20(2):307-12. PubMed ID: 8730222
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacotherapy to control behavioral symptoms in children with autism.
    Doyle CA; McDougle CJ
    Expert Opin Pharmacother; 2012 Aug; 13(11):1615-29. PubMed ID: 22550944
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical potential and possibilities of using buspirone in the treatment of anxiety disorders].
    Dzampaev AT; Suvorova IA; Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(8):94-104. PubMed ID: 25389538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.